medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab. Crohns Colitis 360 Al Hosani M, Al Hosani N, Alzaabi MN, Alahmad MA, Omar NM, Oribiana CC, Ahmed EF, Ahmed I, Chitra Kumar KK, Hanif S, Barakat KIE, Elsayed KOE, Quraishi MN. PMID: 42381756 [PubMed - in process]
	PHARMACOTHERAPEUTIC INTERVENTIONS FOR PEDIATRIC ULCERATIVE COLITIS. Expert Opin Pharmacother Romano A, Vazzana GF, Romano C. PMID: 42381390 [PubMed - as supplied by publisher]
	ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. J Crohns Colitis Adamina M, Kienle P, Chaparro M, Verstockt B, Minozzi S, Allocca M, Atreya R, Avellaneda N, Barreiro-De Acosta M, Battat R, Bettenworth D, Blumenstein I, Brown SR, Burke JP, Caprioli F, Casanova MJ, Christou N, De Buck Van Overstraeten A, Doherty G, Eder P, El-Hussuna A, Ellul P, Fantini MC, Furfaro F, Greuter T, Hazel K, Holubar S, Kapizioni C, Kopylov U, Leong RW, Leventoglu S, Limdi JK, Noor NM, Papaconstantinou I, Peros G, Pouillon L, Reenaers C, Saibeni S, Schmidt C, Sousa P, Stassen LPS, Uzzan M, Vieujean S, Visser E, Kucharzik T, Gisbert JP, Myrelid P. PMID: 42381162 [PubMed - in process]
	Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials. BioDrugs Ran Z, Chen Y, Miao Y, Wang Y, Gao X, Zhong J, Ding X, Wang C, Zhang X, Ding Y, Hu N, Tang D, Yu J, Qian C, Shen J. PMID: 42380713 [PubMed - as supplied by publisher]
	Anti-OmpC antibodies in Crohn's disease and ulcerative colitis: evidence from a systematic review and meta-analysis. Crohns Colitis 360 Sekla R, Sammar A, Shah A, Oludiran F, Sohaib M, Tawfik M. PMID: 42376683 [PubMed]
	Considerations in reviewing network meta-analyses of heterogeneous clinical trial designs: a methodological review in Crohn's disease and ulcerative colitis. Crohns Colitis 360 Ma C, Collins EB, Wang ST, Teng Y, Stevens W, Panaccione R, Sharma D, Joshi N, Morisset PA, Atreya R, Melmed GY. PMID: 42376682 [PubMed]
	Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort. Inflamm Intest Dis Otagiri S, Aoyama K, Katsurada T, Ito T, Maemoto A, Orii F, Ashida T, Nasuno M, Tanaka H, Ando K, Fujiya M, Yokoyama Y, Motoya S, Nakase H. PMID: 42376456 [PubMed]
	Frequent exposure to biologics is associated with small intestinal bacterial overgrowth in patients with Crohn's disease: a retrospective case-control study. PeerJ Zhao Y, Tao H, Yang Z, Feng X, Li L, Ding Z, Yang Y, Chen L, Wu J, Xu S, Yan Y, Wang H, Shi X, Ma C, Wang F, Wei J. PMID: 42376044 [PubMed - indexed for MEDLINE]
	Update on intestinal ultrasound in pediatric inflammatory bowel disease. Eur J Pediatr Dunay GA, Däbritz J. PMID: 42371204 [PubMed - indexed for MEDLINE]
	When nothing else matters: proctectomy for complex perianal Crohn's disease-indications, timing, techniques, and outcomes. Tech Coloproctol Yamamoto T. PMID: 42371192 [PubMed - as supplied by publisher]
	From Gene Expression to Candidate Biomarkers in Ulcerative Colitis: Aquaporin-9 in Neutrophil Extracellular Traps Formation Pathways. Iran J Med Sci Al-Jamali HZH, Sheikhesmaili F, Moradzad M, Ahmadi A, Jalili A, Nikkhoo B, Rahmani MR, Fakhari S. PMID: 42370017 [PubMed - indexed for MEDLINE]
	Lactylation-Related Genes in Ulcerative Colitis: A Multiomics Mendelian Randomization Study for Therapeutic Target Discovery. Hum Mutat An N, Wang R, Jiao H, Lu Z, Dou Y, Zheng L, Ding Z. PMID: 42369205 [PubMed - indexed for MEDLINE]
	Stoma formation and associated risk factors in patients with Crohn's disease in an Austrian tertiary referral hospital: a retrospective explorative study of long-term follow-up. Crohns Colitis 360 Primas C, Riss S, Pokryszka J, Frick A, Maurer J, Dabsch S, Schreiner P, Reinisch W, Kazemi-Shirazi L, Dawoud C, Pedarnig N, Angermann H, Dejaco C, Trauner M, Novacek G, Waldhör T. PMID: 42368422 [PubMed]
	Cellular senescence in Crohn's disease: a double-edged sword in intestinal fibrosis. Front Immunol Liu J, Yu L. PMID: 42367814 [PubMed - indexed for MEDLINE]
	Unsupervised Machine Learning of Inflammatory Bowel Disease Case Reports Reveals Decades of Evolving Research Themes. J Gastrointestin Liver Dis Ogasawara N. PMID: 42365648 [PubMed - indexed for MEDLINE]
	Bowel Urgency in Inflammatory Bowel Disease: Prevalence, Psychosocial Burden, and Challenges in Assessment. J Gastrointestin Liver Dis Parello S, Del Gaudio A, Murgiano M, Cascella F, Puca P, Scaldaferri F, Napolitano D. PMID: 42365647 [PubMed - indexed for MEDLINE]
	Romanian National Study on the Epidemiology of Inflammatory Bowel Diseases. J Gastrointestin Liver Dis Gheorghe C, Iacob R, Mateescu B, Topala M, Stroie T, Meianu C, State M, Anghel MC, Trifan A, Negreanu L, Cijeschi-Prelipcean C, Seicean A, Pop C, Dumitru E, Dobru D, Goldis A, Tieraru CG, Saftoiu A, Brisc C, Jinga M, Drug V, Bataga S, Gheonea D, Grad S, Dumitrascu D, Tantau A, Gheorghe L, Diculescu M. PMID: 42365638 [PubMed - indexed for MEDLINE]
	Polystyrene nanoplastics trigger ferroptosis to aggravate ulcerative colitis: Integrated multi-database bioinformatics, machine learning, and experimental validation. Chem Biol Interact Gu M, Tian M, Jiang C, Ping G, Chen H, Huang X. PMID: 42364682 [PubMed - as supplied by publisher]
	Latent profile analysis of avoidant/restrictive food intake disorder in patients with inflammatory bowel disease in remission: A cross-sectional study. Medicine (Baltimore) Tian Y, Gao B, Qiao J, Fei H, Wu Y, Xu M. PMID: 42363489 [PubMed - indexed for MEDLINE]
	Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds. BMJ Open Gastroenterol Khan SW, Al Hosani N, Swaid TK, Edan MM, Quraishi MN. PMID: 42362204 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 58119

Seite 1 von 2906



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung